None listed
Conditions
Brief summary
The study aims to investigate the effects of different plant extracts on prolonging satiety in healthy overweight adults. This study utilizes a randomized, double-blinded, crossover design to investigate if specific plant extracts can reduce appetite and increase feelings of fullness. Participants will attend an initial screening and five treatment sessions at the BASE Facility. The primary goal is to understand if these extracts affect how much people eat at lunchtime, while secondary outcomes assess changes in appetite through questionnaires.
Interventions
The study aims to investigate the effectiveness of the satiety-prolonging and appetite-suppressing effects of natural plant extracts, including Momordica charantia, Caralluma fimbriata, Gymnema sylvestre, and Humulus lupulus, on healthy, overweight individuals. This randomized, double-blinded, crossover study will be conducted at the Be Active Sleep Eat (BASE) Facility, Monash University. The study consists of an initial screening and five treatment sessions. Participants first complete an online pre-screening questionnaire to determine eligibility. Those who meet the criteria are invited for an in-person visit at the BASE Facility, where researchers measure their height and weight, provide a detailed briefing on the study procedures, and obtain informed consent. Each participant required to attend a total of 5 treatment sessions (4 interventions and one placebo). Participants are advised to avoid alcohol and strenuous exercise for 24 hours before each treatment session and to fast from 9 PM the previous night. On the day of each session, participants arrive at the facility at 8 AM. Researchers measure their height, weight, and body composition using multi-frequency Bioelectrical Impedance Analysis (mBIA). Throughout each visit, participants complete several questionnaires assessing their feelings related to appetite, mood, food cravings, gastrointestinal condition, and perceptions of the food provided. Participants then consume a fixed-calorie breakfast (approximate calorie content: 1700 kJ). They are advised to finish the breakfast within 15 minutes. Two and a half hours later, they ingest a treatment capsule containing 500 mg of either a plant extract (Momordica charantia, Caralluma fimbriata, Gymnema sylvestre, or Humulus lupulus) or a placebo. An hour after capsule administration, participants eat a standard lunch and can eat as much as they like within a duration of 30 minutes. After the standard lunch, participants complete the same questionnaires again until 2 PM. Additionally, they maintain a 24-hour diet diary until 12 PM the following day, documenting all food and beverage intake. A seven-day washout period is provided between each treatment session to ensure accurate results. To ensure adherence to the intervention, trained researchers will directly supervise participants during key aspects of the study, including the consumption of study capsules, meals, and the completion of questionnaires.
Sponsors
Study design
Eligibility
Inclusion criteria
• 18 years or more • Self-reported as healthy overweight adults with Body Mass Index (BMI) more than 25 kg/m2 • No known health conditions that may affect full participation (e.g., diabetes, cardiovascular disease, liver or thyroid dysfunction or recent major surgery) • Not taking any medications that are known to affect appetite (e.g., diabetic medications, antidepressants, stimulants, appetite suppressants, and chemotherapy drugs) • No gastrointestinal conditions (e.g., Crohn’s disease, ulcerative colitis, coeliac disease and/or recent gastrointestinal surgery involving any body parts involved in digestion) • Not currently cigarette smoking and/or vaping • Not currently pregnant or breastfeeding • Have no known intolerance, sensitivity or allergic reaction to lactose, gluten and/or dairy products • Able to adhere to the study protocol and consume every study food • Available to attend six testing sessions at the Notting Hill BASE Facility
Exclusion criteria
None